Total effective vascular compliance in patients with cirrhosis. Effects of propranolol (Q43897801)

27 November 2017

title

Total effective vascular compliance in patients with cirrhosis. Effects of propranolol (English)

1 reference

27 November 2017

author

Juan Carlos García-Pagan

5

1 reference

27 November 2017

Victoria Andreu

1

1 reference

27 November 2017

Antonia Perello

2

1 reference

27 November 2017

Eduardo Moitinho

3

1 reference

27 November 2017

Angels Escorsell

4

1 reference

27 November 2017

Jaume Bosch

6

1 reference

27 November 2017

Joan Rodés

7

1 reference

27 November 2017

publication date

1 March 2002

1 reference

27 November 2017

published in

Journal of Hepatology

1 reference

27 November 2017

volume

36

1 reference

27 November 2017

issue

3

1 reference

27 November 2017

page(s)

356-361

1 reference

Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900300-2

7 January 2021

Reduced central blood volume in cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900300-2

7 January 2021

Clinical pharmacology, physiology and pathophysiology of superficial veins--2

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900300-2

7 January 2021

Total effective vascular compliance in patients with cirrhosis: a study of the response to acute blood volume expansion

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900300-2

7 January 2021

Hemodynamic effects of blood volume restitution following a hemorrhage in rats with portal hypertension due to cirrhosis of the liver: influence of the extent of portal-systemic shunting

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900300-2

7 January 2021

Pulmonary vascular disorders in portal hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900300-2

7 January 2021

Increased portal venous resistance hinders portal pressure reduction during the administration of beta-adrenergic blocking agents in a portal hypertensive model.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900300-2

7 January 2021

Complications of cirrhosis. I. Portal hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900300-2

7 January 2021

Effects of alpha-adrenergic stimulation and beta-adrenergic blockade on azygos blood flow and splanchnic haemodynamics in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900300-2

7 January 2021

Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900300-2

7 January 2021

Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900300-2

7 January 2021

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900300-2

7 January 2021

Thermodilution cardiac output determination with a single flow-directed catheter

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900300-2

7 January 2021

Total effective compliance, cardiac output and fluid volumes in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900300-2

7 January 2021

Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900300-2

7 January 2021

Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900300-2

7 January 2021

Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900300-2

7 January 2021

Effects of prostaglandin inhibition on systemic and hepatic hemodynamics in patients with cirrhosis of the liver.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900300-2

7 January 2021

Acute and chronic cyclooxygenase blockage in portal-hypertensive rats: influence in nitric oxide biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900300-2

7 January 2021

Atrial natriuretic peptide antagonizes endothelin-induced calcium increase and cell contraction in cultured human hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900300-2

7 January 2021

Glucagon hinders the effects of somatostatin on portal hypertension. A study in rats with partial portal vein ligation.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900300-2

7 January 2021

Increased adrenomedullin levels in cirrhosis: Relationship with hemodynamic abnormalities and vasoconstrictor systems

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900300-2

7 January 2021

Renal and neurohormonal changes following simultaneous administration of systemic vasoconstrictors and dopamine or prostacyclin in cirrhotic patients with hepatorenal syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900300-2

7 January 2021

The sympathetic nervous system in liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900300-2

7 January 2021

Evidence that renal prostaglandins are involved in renal water metabolism in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900300-2

7 January 2021

Chronic blockade of endothelin receptors in cirrhotic rats: Hepatic and hemodynamic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900300-2

7 January 2021

Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900300-2

7 January 2021

Nitric oxide-mediated beta 2-adrenoceptor relaxation is impaired in mesenteric veins from portal-hypertensive rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900300-2

7 January 2021

Carvedilol, a new nonselective beta-blocker with intrinsic anti-alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900300-2

7 January 2021

Beta-blockers of the third generation inhibit endothelin-1 liberation, mRNA production and proliferation of human coronary smooth muscle and endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900300-2

7 January 2021

Reversal of adrenaline-induced increase in azygos blood flow in patients with cirrhosis receiving propranolol

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900300-2

7 January 2021

Effects of Propranolol on Azygos Venous Blood Flow and Hepatic and Systemic Hemodynamics in Cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900300-2

7 January 2021

10.1016/S0168-8278(01)00300-2

Identifiers

DOI

1 reference

27 November 2017

1 reference